文献速递母胎医学产科

无创产前筛查与微阵列比较基因组杂交产前诊断的比较:一项回顾性比较研究

Non-invasive prenatal screening versus prenatal diagnosis by array comparative genomic hybridization: a comparative retrospective study.
PubMed 文献 · Prenat Diagn · 2017-05-23

该回顾性比较研究利用2779例接受侵入性产前诊断的胎儿样本的微阵列比较基因组杂交(aCGH)数据,模拟无创产前筛查(NIPS)检测范围,计算aCGH致病性结果中NIPS不可检出部分的比例。结果显示,aCGH致病/可能致病性结果总体率为5.0%,其中44.0%(95% CI 36.0-52.2)的异常NIPS无法检出,不同指征下不可检出比例不同。作者指出约半数异常aCGH结果标准NIPS无法检出,强调检测前咨询的必要性并说明NIPS的局限性。

要点

  • aCGH致病/可能致病性结果总体率为5.0%,其中44.0%(95% CI 36.0-52.2)的异常NIPS不可检出。
  • 颈项透明层95至99百分位者NIPS不可检出率为28.0%(95% CI 14.3-47.6)。
  • 孕早期高风险结果(不论颈项透明层)NIPS不可检出率为34.2%(95% CI 21.1-50.1)。

核心结论

  • 约半数异常aCGH结果标准NIPS检测无法检出,突显检测前咨询的必要性并说明NIPS的局限性。

研究设计与样本

  • 回顾性比较研究,利用2779例接受侵入性产前诊断的胎儿样本的aCGH数据,模拟NIPS检测21、18、13三体、X单体、47,XXX、47,XYY和47,XXY。

主要发现

  • 颈项透明层95至99百分位者aCGH检出异常中NIPS不可检出率为28.0%(95% CI 14.3-47.6)。
  • 颈项透明层大于99百分位者NIPS不可检出率为14.3%(95% CI 5.0-34.6)。
  • 孕早期高风险结果(不论颈项透明层)NIPS不可检出率为34.2%(95% CI 21.1-50.1)。
  • 孕中期标志物异常者NIPS不可检出率为52.4%(95% CI 32.4-71.7)。
  • 高龄孕妇NIPS不可检出率为50.0%(95% CI 26.8-73.2)。

关键数值与推荐

  • 模拟NIPS检测范围包括21、18、13三体、X单体、47,XXX、47,XYY和47,XXY。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To calculate the proportion of array comparative genomic hybridization (aCGH) pathogenic results, that would not be detectable by non-invasive prenatal screening (NIPS). METHODS: This is a comparative study using data from 2779 fetuses, which underwent invasive prenatal diagnosis, and the samples were analyzed using aCGH. The simulated NIPS assay would test for trisomies 21, 18, 13, monosomy X, 47, XXX, 47, XYY, and 47, XXY. Indications for invasive testing were grouped into categories and the absolute, relative rates of pathogenic/likely pathogenic results of aCGH analysis that would not be detectable by NIPS were calculated. RESULTS: The expected rate of aCGH-detected abnormalities that would not be detectable by NIPS was 28.0% (95% CI 14.3-47.6) for nuchal translucency (NT) 95 to 99th centile; 14.3% (95% 5.0-34.6) for NT > 99th centile; 34.2% (95% CI 21.1-50.1) for high-risk first-trimester results (regardless of NT); 52.4% (95% CI 32.4-71.7) for second-trimester markers; and 50.0% (95% CI 26.8-73.2) for advanced maternal age. The overall rate of aCGH pathogenic/likely pathogenic results was 5.0% and 44.0% (95% CI 36.0-52.2) of them would not be detected by NIPS. CONCLUSIONS: Approximately half of the abnormal aCGH results would not be detectable by standard NIPS assays, highlighting the necessity of pre-test counseling, and illustrating the limitations of NIPS. © 2017 John Wiley & Sons, Ltd.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Sotiriadis A, Papoulidis I, Siomou E, et al. Non-invasive prenatal screening versus prenatal diagnosis by array comparative genomic hybridization: a comparative retrospective study. Prenat Diagn. 2017. PMID: 28406537. doi:10.1002/pd.5051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。